Filing Details
- Accession Number:
- 0001179110-15-009306
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-08 16:01:35
- Reporting Period:
- 2015-06-04
- Filing Date:
- 2015-06-08
- Accepted Time:
- 2015-06-08 16:01:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1360886 | Osiris Therapeutics Inc. | OSIR | Biological Products, (No Disgnostic Substances) (2836) | 710881115 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1625312 | Ivan Gregory Law | C/O Osiris Therapeutics, Inc. 7015 Albert Einstein Drive Columbia MD 21046 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-06-04 | 100 | $18.83 | 100 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Option (right to buy) | $13.05 | 2014-11-17 | 2024-11-17 | 20,000 | 20,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2024-11-17 | 20,000 | 20,000 | Direct |